Pharmaceutical Company Agrees To Pay $22 Million To Resolve Alleged False Claims Act and Anti-Kickback Statute Charges

The US Department of Justice recently announced that pharmaceutical company Biogen, Inc. (Biogen), agreed to pay $22 million to settle charges filed through the federal False Claims Act. The company, located in Cambridge, Massachusetts, was charged with improperly using foundations as a means to pay the copays for Medi...